Evaluation of pulmonary infiltrates in patients after stem cell transplantation

References

• Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968;2 (7583):1366–1369.
   PubMed Web of Science ®Google Scholar
• Anonymous, Annual numbers of blood and marrow transplants worldwide 1970–2002. www.ibmtr.org/summar-ysldset 2005; The 2003 BMT Summary Slides with Guide.
   Google Scholar
• Anonymous, Allogeneic transplants in patients >20 years registered with IBMTR, 1989–2002. www.ibmtr.org/summarysldset 2005; The 2003 BMT Summary Slides with Guide.
   Google Scholar
• NMDP. 2003. www.nmdpresearch.org. Accessed.
   Google Scholar
• Keil F, Prinz E, Moser K, Mambalter C, Kalhs P, Worel N, Rabitsch W, Schulenburg A, Mitterbauer M, Greinix H. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival. Transplantation 2003;76 (1):230–236.
   PubMed Web of Science ®Google Scholar
• Yang MH, Chiou TJ, Chao TC, Hsiao LT, Chen PM. Delayed rejection after initial engraftment in non-myelo-ablative bone marrow transplantation. J Chin Med Assoc 2003;66(11):682–688.
   PubMedGoogle Scholar
• Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors. Blood 2002;100(13) :4358–4366.
   PubMed Web of Science ®Google Scholar
• Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26(4):781–803, quiz 804–5.
   PubMed Web of Science ®Google Scholar
• Krowka MJ, Rosenow 3rd, EC. Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 1985;87 (2):237–246.
   PubMed Web of Science ®Google Scholar
• Reed EC. Infectious complications during autotransplanta-tion. Hematol Oncol Chin North Am 1993;7(3):717–735.
   PubMed Web of Science ®Google Scholar
• and others Witherspoon RP, Storb R, Ochs HD, Fluornoy N, Kopecky KJ, Sullivan KM, Deeg JH, Sosa R, Noel DR, Atkinson K. Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treat-ment. Blood 1981;58(2):360–368.
   PubMed Web of Science ®Google Scholar
• Witherspoon RP, Matthews D, Stott, R, Atkinson K, Cheever M, Deeg HJ, Doney K, Kalbfleisch J, Noel D, Prentice R, and others. Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease. Transplantation 1984;37 (2):145–150.
   PubMed Web of Science ®Google Scholar
• Winston DJ, Territo MC, Ho WG, Miller MJ, Gale RP, Golde DW. Alveolar macrophage dysfunction in human bone marrow transplant recipients. Am J Med 1982;73(6): 859–866.
   PubMed Web of Science ®Google Scholar
• Atkinson K. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry. Bone Marrow Transplant 1986;1(2):121–132.
   Google Scholar
• Warren HS, Atkinson K, Pembrey RG, Biggs JC. Human bone marrow allograft recipients: Production of, and responsiveness to, interleukin 2. J Immunol 1983;131(4): 1771–1775.
   PubMed Web of Science ®Google Scholar
• Dykewicz CA. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Chin Infect Dis 2001;33(2):139–144.
   PubMed Web of Science ®Google Scholar
• Lyytikainen O, Ruutu T, Volin L, Lautenschlager I, Jokipü L, Tüttanen L, Ruutu P. Late onset Pneumocystis carinü pneumonia following allogeneic bone marrow transplan-tation. Bone Marrow Transplant 1996;17 (6): 1057–1059.
   PubMedGoogle Scholar
• Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalo-virus disease after allogeneic marrow transplant. Ann Intern Med 1993;118(3):173–178.
   PubMed Web of Science ®Google Scholar
• and others Sakamaki H, Yuasa K, Goto H, Tanikawa S, Akiyama H, Onozawa Y, Okamoto R, Maeda Y, Sasaki T, Kaku H. Comparison of cytomegalovirus (CMV) antigene-mia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation. Bone Marrow Transplant 1997;20(2):143–147.
   PubMed Web of Science ®Google Scholar
• Winston DJ, Ho WG, Bartoni K, Du Mond C, Ebeling DF, Buhles WC, Champlin RE. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Ann Intern Med 1993;118(3):179–184.
   Google Scholar
• Winston DJ, Yeager AM, Chandrasekar PH, Snydman DR, Petersen FB, Territo MC. Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation. Chin Infect Dis 2003;36(6):749–758.
   PubMed Web of Science ®Google Scholar
• Reich G, Mapara MY, Reichardt P, Dorken B, Maschmeyer G. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: Comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 2001;27 (5):525— 529.
   PubMed Web of Science ®Google Scholar
• Mossad SB, Longworth DL, Goormastic M, Serkey JM, Keys TF, Bolwell BJ. Early infectious complications in autologous bone marrow transplantation: A review of 219 patients. Bone Marrow Transplant 1996;18(2):265–271.
   PubMed Web of Science ®Google Scholar
• and others Kruger W, Russmann B, Kroger N, Salomon C, Ekopf N, Elsner HA, Kaulfers PM, Mack D, Fuchs N, Durken M. Early infections in patients undergoing bone marrow or blood stem cell transplantation—A 7 year single centre investigation of 409 cases. Bone Marrow Transplant 1999;23(6):589–597.
   PubMed Web of Science ®Google Scholar
• Martino R, Caballero MD, Canals C, San Miguel J, Sierra J, Rovira M, Solano C, Bargay J, Perez-Simon J, Leon A, and others. Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001;28(4): 341–347.
   Google Scholar
• Chen CS, Boeckh M, Seidel K, Clark JG, Kansu E, Madtes DK, Wagner JL, Witherspoon RP, Anasetti C, Appelbaum FR, and others. Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32(5): 515–522.
   PubMed Web of Science ®Google Scholar
• Brown PD, Lerner SA. Community-acquired pneumonia. Lancet 1998;352 (9136):1295— 1302.
   PubMed Web of Science ®Google Scholar
• Souza JP, Boeckh M, Gooley TA, Flowers ME, Crawford SW. High rates of Pneumocystis carinü pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Chin Infect Dis 1999;29(6):1467–1471.
   PubMed Web of Science ®Google Scholar
• Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993;147(6 Pt 1):1601–1606.
   PubMed Web of Science ®Google Scholar
• Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J, Jr, Crawford JM, Ferrara JL. An experimental model of idiopathic pneumonia syndrome after bone marrow trans-plantation: I. The roles of minor H antigens and endotoxin. Blood 1996; 88 (8): 3230–3239.
   Google Scholar
• Cooke KR, Hill GR, Gerbitz A, Kobzik L, Martin TR, Crawford JM, Brewer JP, Ferrara JL. Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: Potential role for a gut-lung axis of inflammation. J Immunol 2000;165(11):6612–6619.
   PubMed Web of Science ®Google Scholar
• Rubio C, Hill ME, Milan S, O'Brien ME, Cunningham D. Idiopathic pneumonia syndrome after high-dose chemother-apy for relapsed Hodgkin's disease. Br J Cancer 1997;75 (7) :1044–1048.
   Google Scholar
• Wingard JR, Mellits ED, Sostrin MB, Chen DY, Burns WH, Santos GW, Vriesendorp HM, Beschorner WE, Saral R. Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution. Medicine 1988;67 (3):175–186.
   Google Scholar
• Wingard JR, Sostrin MB, Vriesendorp HM, Mellits ED, Santos GW, Fuller DJ, Braine HG, Yeager AM, Burns WH, Saral R. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1988;46(1):61–65.
   PubMed Web of Science ®Google Scholar
• Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HE, Kolb HJ, Hartz AJ, Rimm AA. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Int Med 1986;104(2):168–175.
   PubMed Web of Science ®Google Scholar
• Pecego R, Hill R, Appelbaum FR, Amos D, Buckner CD, Fefer A, Thomas ED. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1986;42(5):515–517.
   PubMed Web of Science ®Google Scholar
• Nusair S, Breuer R, Shapira MY, Berkman N, Or R. Low incidence of pulmonary complications following nonmyelo-ablative stem cell transplantation. [see comment]. Eur Respir J 2004;23(3):440–445.
   PubMed Web of Science ®Google Scholar
• Granena A, Carreras E, Rozman C, Salgado C, Sierra J, Algara M, Rovira M, Valls A. Interstitial pneumonitis after BMT: 15 years experience in a single institution. Bone Marrow Transplant 1993;11 (6): 453— 458 .
   PubMed Web of Science ®Google Scholar
• Crawford SW, Longton G, Storb R. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1993;12(3) :225–231 .
   PubMed Web of Science ®Google Scholar
• Atkinson K, Nivison-Smith I, Dodds A, Concannon A, Milliken S, Downs K. A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophyl-actic ganciclovir therapy in 1989. Bone Marrow Transplant 1998;21(7):691–695.
   PubMed Web of Science ®Google Scholar
• Kantrow SP, Hackman RC, Boeckh M, Myerson D, Crawford SW. Idiopathic pneumonia syndrome: Changing spectrum of lung injury after marrow transplantation. Transplantation 1997;63(8): 1079–1086.
   PubMed Web of Science ®Google Scholar
• and others Fukuda T, Hackman RC, Guthrie KA, Sandmaier BM, Boeckh M, Mans MB, Maloney DG, Deeg HJ, Martin PJ, Storb RF. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional con-ditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003;102 (8): 2777— 2785.
   PubMed Web of Science ®Google Scholar
• Aronin PA, Mahaley Jr, MS, Rudnick SA, Dudka L, Donohue JF, Selker RG, Moore P. Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: An assessment of risk factors. N Engl J Med 1980;303(4): 183–188.
   PubMed Web of Science ®Google Scholar
• and others Wheeler C, Antin JH, Churchill WH, Come SE, Smith BR, Bubley GJ, Rosenthal DS, Rappaport JM, Ault KA, Schnipper LE. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: A dose-finding study. J Clin Oncol 1990;8(4):648–656.
   PubMed Web of Science ®Google Scholar
• Deeg HJ, Storer B, Slattery JT, Anasetti C, Doney KC, Hansen JA, Kiem HP, Martin PJ, Petersdorf E, Radich JP, and others. Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood 2002;100 (4): 1201— 1207.
   PubMed Web of Science ®Google Scholar
• Radich JP, Gooley T, Bensinger W, Chauncey T, Clift R, Flowers M, Martin P, Slattery J, Sultan D, Appelbaum FR. HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen. Blood 2003;102(1): 31–35.
   PubMed Web of Science ®Google Scholar
• Hartman AR, Williams SF, Dillon JJ. Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosph-amide vs total body irradiation: A meta-analysis. Bone Marrow Transplant 1998;22(5):439–443.
   PubMed Web of Science ®Google Scholar
• Petersen FB, Deeg HJ, Buckner CD, Appelbaum FR, Storb R, Clift RA, Sanders JE, Bensinger WI, Witherspoon RP, Sullivan KM, and others. Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide—A phase I trial. Int J Radiat Oncol Biol Phys 1992;23 (5) : 1027–1032.
   PubMed Web of Science ®Google Scholar
• Ozsahin M, Belkacemi Y, Pene F, Laporte J, Rio B, Leblond V, Korbas D, Touboul E, Gorin NC, Schlienger M, and others. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation. Int J Radiat Oncol Biol Phys 1996;34(1):71–77.
   PubMed Web of Science ®Google Scholar
• Wong R, Rondon G, Saliba RM, Shannon VR, Giralt SA, Champlin RE, Ueno NT. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer. Bone Marrow Transplant 2003;31 (12) :1157–1163.
   PubMed Web of Science ®Google Scholar
• Cooke KR, Hill GR, Gerbitz A, Kobzik L, Martin TR, Crawford JM, Brewer JP, Ferrara JL. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 2000;70(2):272–279.
   PubMed Web of Science ®Google Scholar
• Clark JG, Madtes DK, Martin TR, Hackman RC, Farrand AL, Crawford SW. Idiopathic pneumonia after bone marrow transplantation: Cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment. [see comment] . Crit Care Med 1999;27 (9): 1800–1806.
   PubMed Web of Science ®Google Scholar
• Yanik G, Hellerstedt B, Custer J, Hutchinson R, Kwon D, Ferrara JL, Uberti J, Cooke KR. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002;8(7):395–400.
   PubMed Web of Science ®Google Scholar
• Yanik GA, Levine JE, Ferrara JLM, Uberti JP, Ho VT, Antin JH, Cooke KR. Survival following etanercept therapy for the treatment of idiopathic pneumonia syndrome post allogeneic stem cell transplantation. Blood 2004;104(11):354.
   Web of Science ®Google Scholar
• Robbins RA, Linder J, Stahl MG, Thompson III, AB, Haire W, Kessinger A, Armitage JO, Arneson M, Woods G, Vaughan WP, and others. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. [see com-ment]. Am J Med 1989;87(5):511–518.
   PubMed Web of Science ®Google Scholar
• Afessa B, Tefferi A, Litzow MR, Peters SG. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002;166(10):1364–1368.
   PubMed Web of Science ®Google Scholar
• Chao NJ, Duncan SR, Long GD, Horning SJ, Blume KG. Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Ann Int Med 1991;114(2):145–146.
   PubMed Web of Science ®Google Scholar
• Sisson JH, Thompson AB, Anderson JR, Robbins RA, Spurzem JR, Spence PR, Reed EC, Armitage JO, Vose JM, Arneson MA, and others. Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplan-tation in patients with Hodgkin disease. Am Rev Respir Dis 1992;146 (2):439–443.
   PubMed Web of Science ®Google Scholar
• Metcalf JP, Rennard SI, Reed EC, Haire WD, Sisson JH, Walter T, Robbins RA. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group. Am J Med 1994;96(4):439–443.
   Google Scholar
• Agusti C, Ramirez J, Picado C, Xaubet A, Carreras E, Ballester E, Torres A, Battochia C, Rodriguez-Roisin R. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. A postmortem study. Am J Respir Grit Care Med 1995;151(4):1006–1010.
   Google Scholar
• Lewis ID, DeFor T, Weisdorf DJ. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: Cryptic etiology and uncertain therapy. Bone Marrow Transplant 2000;26(5):539–543.
   PubMed Web of Science ®Google Scholar
• Raptis A, Mavroudis D, Suffredini A, Molldrem J, Rhee FV, Childs R, Phang S, Barrett A. High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients. Bone Marrow Transplant 1999;24(8):879–883.
   PubMed Web of Science ®Google Scholar
• Wojno KJ, Vogelsang GB, Beschorner WE, Santos GW. Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease. Transplantation 1994;57(1):88–92.
   PubMed Web of Science ®Google Scholar
• Witte RJ, Gurney JW, Robbins RA, Linder J, Rennard SI, Arneson M, Vaughan WP, Reed EC, Dicke KA. Diffuse pulmonary alveolar hemorrhage after bone marrow trans-plantation: Radiographic findings in 39 patients. Am J Roentgenol 1991.
   Google Scholar
• Golde DW, Drew WL, Klein HZ, Finley TN, Cline MJ. Occult pulmonary haemorrhage in leukaemia. Br Med J 1975;2(5964):166–168.
   PubMedGoogle Scholar
• Afessa B, Tefferi A, Litzow MR, Krowka MJ, Wylam ME, Peters SG. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Grit Care Med 2002;166(5):641–645.
   PubMed Web of Science ®Google Scholar
• Sherman JM, Winnie G, Thomassen MJ, Abdul-Karim FW, Boat TF. Time course of hemosiderin production and clearance by human pulmonary macrophages. Chest 1984;86(3):409–411.
   Google Scholar
• Hicks K, Peng D, Gajewski JL. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Bone Marrow Transplant 2002;30(12):975–978.
   PubMed Web of Science ®Google Scholar
• Henke D, Falk RJ, Gabriel DA. Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Int Med 2004;140(6):493–494.
   PubMed Web of Science ®Google Scholar
• Lee CK, Gingrich RD, Hohl RJ, Ajram KA. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995;16(1):175–182.
   PubMed Web of Science ®Google Scholar
• Horn TD. Acute cutaneous eruptions after marrow ablation: Roses by other names? J Cutan Pathol 1994;21(5):385–392.
   PubMed Web of Science ®Google Scholar
• Bayer-Garner IB, Smoller BR. The spectrum of cutaneous disease in multiple myeloma. J Am Acad Dermatol 2003;48(4):497–507.
   PubMed Web of Science ®Google Scholar
• Bauer DJ, Hood AF, Horn TD. Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery. Arch Dermatol 1993;129(7):855–858.
   PubMed Web of Science ®Google Scholar
• Maiolino A, Biasoli I, Lima J, Portugal AC, Pulcheri W, Nucci M. Engraftment syndrome following autologous hematopoietic stem cell transplantation: Definition of diagnostic criteria. Bone Marrow Transplant 2003;31(5): 393–397.
   PubMed Web of Science ®Google Scholar
• Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27(9):893–898.
   PubMed Web of Science ®Google Scholar
• Edenfield WJ, Moores LK, Goodwin G, Lee N. An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose. Bone Marrow Transplant 2000;25(4):405–409.
   PubMed Web of Science ®Google Scholar
• Akasheh M, Eastwood D, Vesole DH. Engraftment syndrome after autologous hematopoietic stem cell transplant sup-ported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-C SF). Bone Marrow Transplant 2003;31 (2):113–116.
   PubMed Web of Science ®Google Scholar
• Madero L, Vicent MG, Sevilla J, Prudencio M, Rodriguez F, Diaz MA. Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002;30 (6):355–358.
   PubMed Web of Science ®Google Scholar
• Salat C, Holler E, Schleuning M, Eisele B, Reinhardt B, Kolb H, Pihusch R, Domrath R, Hiller E. Levels of the terminal complement complex, C3a-desArg and Cl-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation. Ann Hematol 1995;71 (6):271–274.
   PubMed Web of Science ®Google Scholar
• Ravoet C, Feremans W, Husson B, Majois F, Kentos A, Lambermont M, Wallef G, Capel P, Beauduin M, Delannoy A. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transplant 1996;18(5):943–947.
   PubMed Web of Science ®Google Scholar
• Capizzi SA, Kumar S, Huneke NE, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Gastineau DA, Prakash UB, Tefferi A. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27 (12):1299–1303.
   PubMed Web of Science ®Google Scholar
• Donowitz GR, Harman C, Pope T, Stewart FM. The role of the chest roentgenogram in febrile neutropenic patients. Arch Int Med 1991;151(4):701–704.
   PubMed Web of Science ®Google Scholar
• Roy V, Ali U, Selby GB. Routine chest radiography for the evaluation of febrile neutropenic patients after autologous stem cell transplantation. Am J Hematol 2000;64(3): 170–174.
   PubMed Web of Science ®Google Scholar
• Heussel CP, Kauczor HU, Heussel GE, Fischer B, Begrich M, Mildenberger P, Thelen M. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: Use of high-resolution computed tomography. J Chin Oncol 1999;17(3):796–805.
   PubMed Web of Science ®Google Scholar
• Barloon TJ, Galvin JR, Mori M, Stanford W, Gingrich RD. High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms. Chest 1991;99(4): 928–933.
   PubMed Web of Science ®Google Scholar
• Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997;19 (8): 801–808.
   Google Scholar
• Hebart H, Loffier J, Meisner C, Serey F, Schmidt D, Bohme A, Martin H, Engel A, Bunje D, Kern WV, and others. Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis 2000;181(5):1713–1719.
   PubMed Web of Science ®Google Scholar
• Williamson EC, Leeming JP, Palmer HM, Steward CG, Warnock D, Marks DI, Millar MR. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction. Br J Haematol 2000;108(1): 132–139.
   PubMed Web of Science ®Google Scholar
• Reiss E, Obayashi T, Orle K, Yoshida M, Zancope-Oliveira RM. Non-culture based diagnostic tests for mycotic infections. Med Mycol 2000;38\(Suppl. 1):147–159.
   PubMedGoogle Scholar
• Rohrlich P, Sarfati J, Mariani P, Duval M, Carol A, Saint-Martin C, Bingen E, Latge JP, Vilmer E. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: Early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996;15(3): 232–237,
   Google Scholar
• Stynen D, Sarfati J, Goris A, Prevost MC, Lesourd M, Kamphuis H, Darras V, Latge JP. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 1992; 60 (6): 2237–2245.
   PubMed Web of Science ®Google Scholar
• Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant adminis-tration of piperacillin and tazobactam. N Engl J Med 2003;349 (24): 2366–2367
   PubMed Web of Science ®Google Scholar
• Verweij PE, Weemaes CM, Curfs JH, Bretagne S, Meis JF. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillo-sis. J Chin Microbiol 2000;38(10):3900–3901.
   Web of Science ®Google Scholar
• Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003;121(3): 448–457.
   Google Scholar
• Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O, Liu KL, Natarajan-Ame S, Lutz P, and others. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Chin Oncol 2002;20 (7) : 1898— 1906.
   PubMed Web of Science ®Google Scholar
• Petraitiene R, Petraitis V, Groll AH, Seth T, Piscitelli S, Candelario M, Field-Ridley A, Avila N, Bacher J, Walsh Tj. Antifungal activity and pharmacokinetics of posacona-zole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: Correlation with galactomannan antigenemia. Antimicrob Agents Chemother 2001;45 (3): 857— 869
   PubMed Web of Science ®Google Scholar
• Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001;91(2): 311–318.
   PubMed Web of Science ®Google Scholar
• Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galacto-mannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002;186 (9) :1297–1306.
   PubMed Web of Science ®Google Scholar
• and others Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoie-tic stem cell transplants: An international consensus. Chin Infect Dis 2002;34(1):7–14.
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and manage-ment of invasive aspergillosis. Lancet Infect Dis 2004;4(6):349–357.
   PubMed Web of Science ®Google Scholar
• Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The city of Hope-Stanford-Syntex CMV study group. N Engl J Med 1991;324(15):1005–1011.
   PubMed Web of Science ®Google Scholar
• Crawford SW, Bowden RA, Hackman RC, Gleaves CA, Meyers JD, Clark JG. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifu-gation culture. Ann Int Med 1988;108 (2) : 180— 185.
   PubMed Web of Science ®Google Scholar
• Slavin MA, Gleaves CA, Schoch HG, Bowden RA. Quantification of cytomegalovirus in bronchoalveolar lavage fluid after allogeneic marrow transplantation by centrifu-gation culture. J Chin Microbiol 1992;30(11):2776–2779.
   Web of Science ®Google Scholar
• Hakki M, Riddell SR, Storek J, Carter RA, Stevens-Ayers T, Sudour P, White K, Corey L, Boeckh M. Immune reconstitution to cytomegalovirus after allogeneic hemato-poietic stem cell transplantation: Impact of host factors, drug therapy, and subclinical reactivation. Blood 2003;102(8): 3060–3067.
   Google Scholar
• Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994;83(7):1971–1979.
   PubMed Web of Science ®Google Scholar
• Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang ML,, Myerson D, Stevens-Ayers T, Flowers ME, Cunningham T, Corey L. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity. Blood 2003;101 (2):407–414.
   Google Scholar
• Gleaves CA, Smith TF, Shuster EA, Pearson GR. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J Chin Microbiol 1984;19(6):917–919.
   Web of Science ®Google Scholar
• Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyers JD. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992;80(5) :1358–1364.
   PubMed Web of Science ®Google Scholar
• Boeckh M, Bowden RA, Gooley T, Myerson D, Corey L. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. Blood 1999;93(5) :1781–1782.
   PubMed Web of Science ®Google Scholar
• Gerna G, Percivalle E, Torsellini M, Revello MG. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes. J Chin Microbiol 1998;36(12):3585–3589.
   Web of Science ®Google Scholar
• and others Einsele H, Ehninger G, Hebart H, Wittkowski KM, Schuler U, Jahn G, Mackes P, Herter M, Klingebiel T, Loffler J. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplan-tation. Blood 1995;86(7):2815–2820.
   PubMed Web of Science ®Google Scholar
• Boeckh M, Gallez-Hawkins GM, Myerson D, Zaia JA, Bowden RA. Plasma polymerase chain reaction for cyto-megalovirus DNA after allogeneic marrow transplantation: Comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation 1997;64(1):108–113.
   PubMed Web of Science ®Google Scholar
• and others Von Muller L, Hampl W, Hinz J, Meisel H, Reip A, Engelmann E, Heilbronn R, Gartner B, Kramer O, Einsele H. High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay. J Chin Microbiol 2002;40(6) :2285–2287.
   Web of Science ®Google Scholar
• Weinberg A, Schissel D, Giller R. Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients. J Chin Microbiol 2002;40(11):4203–4206.
   Web of Science ®Google Scholar
• Preiser W, Brauninger S, Schwerdtfeger R, Ayliffe U, Garson JA, Brink NS, Franck S, Doerr HW, Rabenau HF. Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants. J Chin Virol 2001;20(1-2):59–70.
   PubMed Web of Science ®Google Scholar
• Hebart H, Muller C, Loffler J, Jahn G, Einsele H. Monitoring of CMV infection: A comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation. Bone Marrow Transplant 1996;17(5):861–868.
   PubMed Web of Science ®Google Scholar
• Timsit JF, Misset B, Goldstein FW, Vaury P, Carlet J. Reappraisal of distal diagnostic testing in the diagnosis of ICU-acquired pneumonia. Chest 1995;108 (6) :1632— 1639.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Chastre J. The standardization of broncho-scopic techniques for ventilator-associated pneumonia. Chest 1992;102(5 Suppl. 1):557S–564S.
   PubMed Web of Science ®Google Scholar
• Stover DE, Zaman MB, Hajdu SI, Lange M, Gold J, Armstrong D. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Int Med 1984;101(1):1–7.
   PubMed Web of Science ®Google Scholar
• Milburn HJ, Prentice HG, du Bois RM. Role of broncho-alveolar lavage in the evaluation of interstitial pneumonitis in recipients of bone marrow transplants. Thorax 1987; 42(10):766–772.
   Google Scholar
• Cordonnier C, Bernaudin JF, Bierling P, Huet Y, Vernant JP. Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer 1986;58 (5) :1047–1054.
   Google Scholar
• Cordonnier C, Bernaudin JF, Fleury J, Feuilhade M, Haioun C, Payen D, Huet Y, Atassi K, Vernant JP. Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogeneic bone marrow transplantation. Am Rev Respir Dis 1985;132(5):1118–1123.
   PubMed Web of Science ®Google Scholar
• Heurlin N, Lonnqvist B, Tollemar J, Ehrnst A. Fiberoptic bronchoscopy for diagnosis of opportunistic pulmonary infections after bone marrow transplantation. Scand J Inf Dis 1989;21(4):359–366.
   PubMed Web of Science ®Google Scholar
• and others Rano A, Agusti C, Jimenez P, Angrill J, Benito N, Danes C, Gonzalez J, Rovira M, Pumarola T, Moreno A. Pulmonary infiltrates in non-HIV immunocompromised patients: A diagnostic approach using non-invasive and bronchoscopic procedures. [see comment] . Thorax 2001;56(5):379–387.
   PubMed Web of Science ®Google Scholar
• Gruson D, Hilbert G, Valentino R, Vargas F, Chene G, Bebear C, Allery A, Pigneux A, Gbikpi-Benissan G, Cardinaud JP. Utility of fiberoptic bronchoscopy in neutro-penic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med 2000;28(7): 2224–2230.
   Google Scholar
• Dunagan DP, Baker AM, Hurd DD, Haponik EF. Broncho-scopic evaluation of pulmonary infiltrates following bone marrow transplantation. Chest 1997;111 (1) :135–141.
   PubMed Web of Science ®Google Scholar
• Feinstein MB, Mokhtari M, Ferreiro R, Stover DE, Jakubowski A. Fiberoptic bronchoscopy in allogeneic bone marrow transplantation: Findings in the era of serum cytomegalovirus antigen surveillance. Chest 2001; 120 (4): 1094–1100.
   PubMed Web of Science ®Google Scholar
• and others Glazer M, Breuer R, Berkman N, Lossos IS, Kapelushnik J, Nagler A, Naparstek E, Kramer MR, Lafair J, Engelhard D. Use of fiberoptic bronchoscopy in bone marrow transplant recipients. Acta Haematol 1998;99(1):22–26.
   PubMed Web of Science ®Google Scholar
• White P, Bonacum JT, Miller CB. Utility of fiberoptic bronchoscopy in bone marrow transplant patients. Bone Marrow Transplant 1997;20(8):681–687.
   PubMed Web of Science ®Google Scholar
• Hofmeister CC, Forsythe S, Czerlanis C, Stiff P. Should bronchoscopies be routinely performed for post-transplant infiltrates? Blood 2004;104(11), Abstract.
   Google Scholar
• White DA, Wong PW, Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 2000;161(3 Pt 1):723–729.
   PubMed Web of Science ®Google Scholar
• Hachem RY, Boktour MR, Hanna HA, Tarrand JJ, Kontoyiannis DP, Raad I. Serum galactomannan (GM): Which assay (ELISA or LATEX) is useful in diagnosing invasive aspergillosis. Proc Inf Dis Soc Am (Abstract 617) 2004;162.
   Google Scholar
• Lewis JS, Laurel YM, Patterson JE, Jorgensen JH. Impact of fluconazole disk diffusion susceptibility testing on antifungal use in a university teaching hospital. Proc. Inf. Dis Soc Am (Abstract 624) 2004:163.
   Google Scholar
• Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001;98(6):1971–1978.
   PubMed Web of Science ®Google Scholar
• Azzi A, Cesaro S, Laszlo D, Zakrzewska K, Ciappi S, De Sands R, Fanci R, Pesavento G, Calore E, Bosi A. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999;14(2):79–86.
   Google Scholar
• Caserta MT, Mock DJ, Dewhurst S. Human herpesvirus 6. Chin Infect Dis 2001;33(6):829–833.
   PubMed Web of Science ®Google Scholar
• Zerr DM, Gooley TA, Yeung L, Huang ML, Carpenter P, Wade JC, Corey L, Anasetti C. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Chin Infect Dis 2001;33(6):763–771.
   PubMed Web of Science ®Google Scholar
• Cone RW, Huang ML, Corey L, Zeh J, Ashley R, Bowden R. Human herpesvirus 6 infections after bone marrow trans-plantation: Clinical and virologic manifestations. J Inf Dis 1999;179(2):311–318.
   PubMed Web of Science ®Google Scholar
• Wainwright MS, Martin PL, Morse RP, Lacaze M, Provenzale JM, Coleman RE, Morgan MA, Hulette C, Kurtzberg J. Bushnell C and others. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001;50(5):612–619.
   PubMed Web of Science ®Google Scholar
• Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. Human herpesvirus 6 (HHV-6) associated disease follwoing hematopoietic cell transplantation (HCT). Proc Inf Dis Soc Am (Abstract 643) 2004;167.
   Google Scholar